Description

What is GLYXAMBI?

GLYXAMBI is a prescription medication containing two medicines, empagliflozin (JARDIANCE) and linagliptin (TRADJENTA). GLYXAMBI can be used along with diet and exercise to lower blood sugar in adults with type 2 diabetes, and can be used in adults with type 2 diabetes who have known cardiovascular disease when empagliflozin, one of the medicines in GLYXAMBI, is needed to reduce the risk of cardiovascular death.

GLYXAMBI is not for use to lower blood sugar in people with type 1 diabetes. It may increase their risk of diabetic ketoacidosis (increased ketones in the blood or urine). If you have had pancreatitis (inflammation of the pancreas) it is not known if you have a higher chance of getting pancreatitis while taking GLYXAMBI. GLYXAMBI is not for use to lower blood sugar in people with type 2 diabetes who have severe kidney problems, because it may not work.

IMPORTANT SAFETY INFORMATION

Do not take GLYXAMBI if you are allergic to linagliptin (TRADJENTA), empagliflozin (JARDIANCE), or any of the ingredients in GLYXAMBI.

Symptoms of a serious allergic reaction may include:

  • skin rash, itching, flaking, or peeling

  • raised red patches on your skin (hives)

  • swelling of your face, lips, tongue, and throat that may cause difficulty in breathing or swallowing

  • difficulty with swallowing or breathing

If you have any of these symptoms, stop taking GLYXAMBI and call your healthcare provider right away or go to the nearest hospital emergency room.